Jump to:

Bliley PM

RE: Chemosol

Date: 26 Sep 1969
Length: 3 pages
1000033458-1000033460
Jump To Images
bliley_pm 1000033458-1000033460

Abstract

Discusses recent agreement of American Chemosol Corporation "to have carried out through the auspices of the tobacco industry the independent test of Chemosol." States updated protocol being developed by the reactivated subcommittee includes conditions required by "the technical representatives of the nine sponsoring companies" if testing is to go forward. Expresses concern that lack of adherence to outlined requirements will lead to an "invalid result." Indicates expectation of review and approval by "sponsoring representatives at an early date."

Fields

Type
Letter
Author
Wakeham, Helmut R. R., Ph.D. (PM R&D VP)
Vice President and Director of Research & Development, Philip Morris
Author (Organization)
Philip Morris Research Center
Recipient
Austern, H.T.
Recipient (Organization)
Covington & Burling (Tobacco Industry law firm)
Tobacco industry law firm. Was involved in organizing the Whitecoat Project.
Copied
Wood, J.
Bates, W.W. Dr.
Bennett, W. B.
Gregory, N. R.
Harlow, E.S.
Nielson, E. Dr.
Sanford, R. A. Dr.
Senkus, M. Dr.
Spears, Alexander White, III (LOR President & CEO)
Associated with CTR, used as an expert in the Mississippi case.
Named Person
Gargus, J.
Topol, A.
Named Organization
American Chemosol Corporation
Hazelton Laboratories
Keyword
Chemosol
Subject
Additives
cigarette design
industry sponsored research
Research Methods
Tobacco Industry Scientists

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: 1000033458
i PHILIP 'MORRIS U.S.A. RESEARCH CENTER: P.O. BOX 3D, RICHMOND, VIRGINIA 23206 TELEPHONE ~/03)275-8361 September 26, 1969 Mr. H. Thomas. Austern Covington 8~ Burling 888 Sixteenth Street N.W. Washington, D.C.. 20006 re: Chemosol Dear Mr. Austern: As you know, following the recent agreement to your letter of August I, 1967 by the American Chemosol Corporation to have carried out through the auspices of the tobacco industry the independent test of Chemosol, I was asked to bring together the representatives of the nine sponsoring companies for the purpose of agreeing upon a technical program for the test. Accordingly, I reactivated the subcommittee which had previously dealt with the matter of a Chemosol test protocol to be fo!lowed by Hazle- ton Laboratories, and requested this group to contact Hazleton and to up- date the protocol. The new. protocol was presented~ to the technical representatives of the nine sponsoring companies at a meeting tn New York on September 10, I969 at which time the representatives reviewed the protocol in the presence of Mr. James Gargus of Hazleton Laboratories, and agreedl upon certain modifications. At that time we had in hand the comments: submitted by you tn writing through Mr. Allan Topoi, who was also present at the New York meeting. We then requested' the protocol subcommittee to revise the protocol in line with the discussions in New York, and to resubmit it to the technical represen- tatives, the plan being: that when we had had an opportunity to re-examine it, we would attempt to obtain agreement and approval. ~.0000334,~1~ During this period [ have been in close contact with the subcommittee which had a meeting on Monday, September I5, at Hazleton for the purpose of revising the protocol according to our instructions. I understand that you attended that meeting (unannounced) and that you made some rather strong remarks about the effectiveness of the technical representatives in preparing an adequate protocol. BENSON& HEDGES PARLIAMENT PHILIP MORRIS MARLBORO PERSONNA BLADES CLARK GUM
Page 2: 1000033459
Mr. H. Thomas Austern - 2 - September 26, 1969 There are obviously some differences of opinion between you and the technical representatives regarding the conditions under which this test can be properly carried out. I wish to make clear to you a number of points on which the technical representatives are unanimously agreed; and so that there will be no misunderstanding on this score, I am outlining these points in writing, as follows: 1. It is our firm opinion that unless we receive tn writing a certificate or assurances from the Chemosol representatives who supervise the cigaret preparation that the treatment has been applied properly, and that the samples are valid samples for the purpose of testing the Chemosol hypothesis, there isno point in continuing with the bioassay tests. It is, therefore, necessary before any company can properly set up the conditions for applying Chemosol to the test tobacco, that the Chemosol representatives agree to this procedure and, in fact, indicate in as much detail as possible the conditions of the tobacco and the environment in which the application is to be made. There is no doubt in our minds about the need for this kind of a preliminary negotiation with the Chemosol representatives, since they have de- clared in past documents the necessity for precise humidity control, etc., if the treatment is to be successful. 2. It is also, in our opinion, necessary for a technical representative from the industry to be present at the negotiations with Chemosol regarding the conditions of Chemosol application, since there will undoubtedly be questions of a technical nature coming up in the dis- cussion which will need to be answered during those negotiations. Some of their demands may not be technically feasible; and unnecessary or impractical concessions made in the absence of technical advice may be embarrass ing. 3, During the course of the tests~ by Hazleton the work must be followed by a technical liaison representative of the industry. The industry representative must be able to certify at the end that Hazleton has followed the requirements of the protocol, and has employed, adequate quality control measures in the course of the tests. It is not enough simply to receive an invoice at regular intervals from Hazleton as an indication of their progress. The monitoring of the program by a tech- nical representative is just good business practice and should be follow ed in this case. ~.00003~459 We hope that you will see fit to keep these points in mind in your considerations of the Chemosol test program. As you. know, there are many factors which can go astray in the course of the test, factors which are vital to the success of the test in terms of giving a valid result, and we need to follow this path very care- fully.
Page 3: 1000033460
Mr. H. Thomas Austern - 3 - September 26, 1969 The protocol subgroup is well along with the description of how the cigaret samples are to be prepared. We fully expect this and the revised bioassay protocol to be reviewed and approved by the sponsoring representatives at an early date. Sincerely yours, H " Wakeham, Vice President Corporate Research and Development cc: Mr. E. S. Harlow Dr. A. W. Spears Dr. W. W. Bates Dr. R. A. Sanford Dr. E. Nielson Mr. W. B. Bennett Mr. N. R. Gregory Mr. J. Wood Dr. M. Senkus

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: